2020-2027 Analysis and Review Polyene Phosphatidylcholine Market

Polyene Phosphatidylcholine Market

Polyene Phosphatidylcholine Market by Clinical Application (Liver Diseases, Dietary Supplements, and Others) by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

04-06-2020 REP-HC-5106 40 Tables 115 pages Format

The polyene phosphatidylcholine market was valued at USD 265.7 Mn by 2019. The rising prevalence of hepatic disorders worldwide primarily drives market growth. Additionally, the growing significance of polyene phosphatidylcholine as a dietary supplement will further propel the market growth in the near future.

Polyene Phosphatidylcholine Market

Polyene phosphatidylcholine is an unsaturated version of phosphatidylcholine which is derived from natural sources such as soybeans, eggs, sunflowers, mustard, etc. it occurs naturally in the human cells. It is widely employed for its therapeutic efficacy against hepatic disorders, ulcerative colitis, cognitive functions, etc. commercially available as injectable and capsules. Technological advancement in nutrition science has increased the demand for dietary supplements enriched in polyene phosphatidylcholine.

The major segments related to the polyene phosphatidylcholine market are: 

By Clinical Application (2017–2027; US$ Mn)

Liver Diseases

Dietary Supplements

Others

By Distribution Channel (2017–2027; US$ Mn)

Hospital Pharmacy

Retail Pharmacy

Others

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global polyene phosphatidylcholine market
  • The overall segmentation of the polyene phosphatidylcholine market, by clinical application, distribution channel, and geography is minutely studied. Liver diseases and hospital pharmacy are dominating the clinical application and distribution channel segments respectively
  • Growing incidence of liver diseases worldwide
  • Increasing demand for in the nutraceutical segment owing to its lipotropic effects will further accentuate the market growth

Report gist?

  • The study of the global polyene phosphatidylcholine market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers the qualitative and quantitative analysis of the overall market segmented on the basis of clinical application and distribution channel and categorization of the same at the geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. The compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the pharmaceutical manufacturers actively engaged in the production and marketing of polyene phosphatidylcholine on account of the growing incidence of liver diseases worldwide
  • The report will benefit dieticians engaged in the recommendation of dietary supplements enriched with polyene phosphatidylcholine owing to its lipotropic effects
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to polyene phosphatidylcholine market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Liver diseases are spearheading the clinical application segment for the polyene phosphatidylcholine market. According to the latest statistics provided by the World Health Organization (WHO), approximately 2 million people die due to liver diseases each year across the globe. The various types of liver diseases frequently encountered in human beings are Hepatitis, A, B, C, liver cirrhosis, fatty liver disease, hemochromatosis, etc. The early clinical manifestations associated with liver diseases are yellowish eyes and skin, dark urine, pale stool color, swelling of legs and ankles, etc. Dietary supplements are gaining immense popularity since the last 2 decades on account of its lipotropic activity which prevents the excess lipid migration from the liver to blood vessels thereby preventing the occurrence of cardiovascular complications. Additionally, clinical studies have reported that polyene phosphatidylcholine is vital in liver repair, facilitates dissolving of gallstones, and eases the pain associated with ulcerative colitis.

Hospital pharmacy is presently the supreme leader in the distribution channel segment for the polyene phosphatidylcholine market. The drug is associated with severe side effects such as pain, itching, edema, at the site of injection and diarrhea, and nausea for oral formulations, hence it is mandatory for the precise dispensing of medications under the supervision of hospital pharmacist. Retail pharmacy is expected to register significant market growth in the near future on account of access to government-subsidized essential medications in the developing regions.

North America is presently leading the geography segment for the polyene phosphatidylcholine market. The rising prevalence of hepatic disorders primarily drives market growth in the region. According to the latest statistics provided by the Center for Disease Control and Prevention (CDC), approximately 4.5 million people in the United States are diagnosed with liver disease. Developed healthcare infrastructure and affordable reimbursement scenarios further drive the market growth in the region. Europe is the second-largest regional market in the regional segment for the polyene phosphatidylcholine market. The supportive regulatory environment provides by the European Medical Agency for the manufacturing of polyene phosphatidylcholine drug formulations drives the market growth in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for the polyene phosphatidylcholine market. Developing healthcare infrastructure and flourishing generic drug formulations market together provide a positive thrust to the market growth in the Asia Pacific region.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.